SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-22-017302
Filing Date
2022-11-10
Accepted
2022-11-10 09:00:21
Documents
14
Period of Report
2022-11-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K imrx-20221110x8k.htm   iXBRL 8-K 38637
2 EX-99.1 imrx-20221110xex99d1.htm EX-99.1 218477
3 GRAPHIC imrx-20221110xex99d1002.jpg GRAPHIC 6512
  Complete submission text file 0001558370-22-017302.txt   404633

Data Files

Seq Description Document Type Size
4 EX-101.SCH imrx-20221110.xsd EX-101.SCH 3159
5 EX-101.LAB imrx-20221110_lab.xml EX-101.LAB 16581
6 EX-101.PRE imrx-20221110_pre.xml EX-101.PRE 10463
8 EXTRACTED XBRL INSTANCE DOCUMENT imrx-20221110x8k_htm.xml XML 5093
Mailing Address 245 MAIN STREET, SECOND FLOOR CAMBRIDGE MA 02142
Business Address 245 MAIN STREET, SECOND FLOOR CAMBRIDGE MA 02142 617-500-8080
Immuneering Corp (Filer) CIK: 0001790340 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40675 | Film No.: 221375206
SIC: 2834 Pharmaceutical Preparations